These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29248676)

  • 1. Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model.
    Carradori D; Balducci C; Re F; Brambilla D; Le Droumaguet B; Flores O; Gaudin A; Mura S; Forloni G; Ordoñez-Gutierrez L; Wandosell F; Masserini M; Couvreur P; Nicolas J; Andrieux K
    Nanomedicine; 2018 Feb; 14(2):609-618. PubMed ID: 29248676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
    Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
    PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.
    Kim HD; Tahara K; Maxwell JA; Lalonde R; Fukuiwa T; Fujihashi K; Van Kampen KR; Kong FK; Tang DC; Fukuchi K
    J Gene Med; 2007 Feb; 9(2):88-98. PubMed ID: 17219449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM1-Modified Lipoprotein-like Nanoparticle: Multifunctional Nanoplatform for the Combination Therapy of Alzheimer's Disease.
    Huang M; Hu M; Song Q; Song H; Huang J; Gu X; Wang X; Chen J; Kang T; Feng X; Jiang D; Zheng G; Chen H; Gao X
    ACS Nano; 2015 Nov; 9(11):10801-16. PubMed ID: 26440073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
    Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT
    J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.
    Dodart JC; Bales KR; Gannon KS; Greene SJ; DeMattos RB; Mathis C; DeLong CA; Wu S; Wu X; Holtzman DM; Paul SM
    Nat Neurosci; 2002 May; 5(5):452-7. PubMed ID: 11941374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue.
    Canovi M; Markoutsa E; Lazar AN; Pampalakis G; Clemente C; Re F; Sesana S; Masserini M; Salmona M; Duyckaerts C; Flores O; Gobbi M; Antimisiaris SG
    Biomaterials; 2011 Aug; 32(23):5489-97. PubMed ID: 21529932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
    Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
    Kim HD; Jin JJ; Maxwell JA; Fukuchi K
    Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripherally administered sera antibodies recognizing amyloid-β oligomers mitigate Alzheimer's disease-like pathology and cognitive decline in aged 3× Tg-AD mice.
    Wang HC; Yu YZ; Liu S; Zhao M; Xu Q
    Vaccine; 2016 Apr; 34(15):1758-66. PubMed ID: 26945100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease of ERK/MAPK overactivation in prefrontal cortex reverses early memory deficit in a mouse model of Alzheimer's disease.
    Feld M; Krawczyk MC; Sol Fustiñana M; Blake MG; Baratti CM; Romano A; Boccia MM
    J Alzheimers Dis; 2014; 40(1):69-82. PubMed ID: 24334722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent improvements in learning and memory deficits in APPPS1-21 transgenic mice treated with the orally active Aβ toxicity inhibitor SEN1500.
    Lo AC; Tesseur I; Scopes DI; Nerou E; Callaerts-Vegh Z; Vermaercke B; Treherne JM; De Strooper B; D'Hooge R
    Neuropharmacology; 2013 Dec; 75():458-66. PubMed ID: 24035915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
    Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S
    Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.
    Muthukumaran K; Kanwar A; Vegh C; Marginean A; Elliott A; Guilbeault N; Badour A; Sikorska M; Cohen J; Pandey S
    J Alzheimers Dis; 2018; 61(1):221-236. PubMed ID: 29154270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norovirus P particle-based active Aβ immunotherapy elicits sufficient immunogenicity and improves cognitive capacity in a mouse model of Alzheimer's disease.
    Fu L; Li Y; Hu Y; Zheng Y; Yu B; Zhang H; Wu J; Wu H; Yu X; Kong W
    Sci Rep; 2017 Jan; 7():41041. PubMed ID: 28106117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial memory recovery in Alzheimer's rat model by electromagnetic field exposure.
    Akbarnejad Z; Esmaeilpour K; Shabani M; Asadi-Shekaari M; Saeedi Goraghani M; Ahmadi-Zeidabadi M
    Int J Neurosci; 2018 Aug; 128(8):691-696. PubMed ID: 29185809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of amyloid-β42 oligomer-specific monoclonal antibody improved memory performance in SAMP8 mice.
    Zhang Y; He JS; Wang X; Wang J; Bao FX; Pang SY; Yin F; Hu HG; Peng XL; Sun WM; Zheng YP; Hou LL; Hong T
    J Alzheimers Dis; 2011; 23(3):551-61. PubMed ID: 21297277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
    Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
    Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation.
    Xu PX; Wang SW; Yu XL; Su YJ; Wang T; Zhou WW; Zhang H; Wang YJ; Liu RT
    Behav Brain Res; 2014 May; 264():173-80. PubMed ID: 24512768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.